GILEAD SCIENCES, INC. — Director's Dealing 2013

Sep 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-09-03

Reporting Person: MARTIN JOHN C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-03	Common Stock	M	282242	$7.6325	Acquired	4339363	Direct
2013-09-03	Common Stock	S	267742	$60.9486	Disposed	4071621	Direct
2013-09-03	Common Stock	S	14500	$61.4476	Disposed	4057121	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-03	Non-Qualified Stock option (right to buy)	$7.6325	M	282242	Disposed	2014-01-28	Common Stock (282242)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $60.35 to $61.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $61.36 to $61.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.